Mazzoni A - Search Results

1

Sister-chromatid exchanges, chromosomal aberrations and cytotoxicity produced by topoisomerase II-targeted drugs in sensitive (A2780) and resistant (A2780-DX3) human ovarian cancer cells: correlations with the formation of DNA double-strand breaks.

Noviello E, Aluigi MG, Cimoli G, Rovini E, Mazzoni A, Parodi S, De Sessa F, Russo P. Noviello E, et al. Among authors: mazzoni a. Mutat Res. 1994 Nov 1;311(1):21-9. doi: 10.1016/0027-5107(94)90069-8. Mutat Res. 1994. PMID: 7526171

2

"Atypical" multidrug resistance in human ovarian cancer cell line A2780 selected for resistance to doxorubicin (A2780 DX3).

Cimoli G, Valenti M, Noviello E, Parodi S, Mazzoni A, Rovini E, De Sessa F, Russo P. Cimoli G, et al. Among authors: mazzoni a. J Cancer Res Clin Oncol. 1995;121(3):155-63. doi: 10.1007/BF01198097. J Cancer Res Clin Oncol. 1995. PMID: 7713987

3

Reversal of "atypical"-multidrug resistance by recombinant human tumor necrosis factor in the human ovarian cancer cell line A2780-DX3.

Cimoli G, Valenti M, Parodi S, Mazzoni A, De Sessa F, Conte P, Russo P. Cimoli G, et al. Among authors: mazzoni a. Oncol Res. 1993;5(8):311-23. Oncol Res. 1993. PMID: 8012063

4

Generation and characterization of a low-degree drug-resistant human tumor cell line.

Mazzoni A, Trave F, Russo P, Nicolin A, Rustum YM. Mazzoni A, et al. Oncology. 1990;47(6):488-94. doi: 10.1159/000226878. Oncology. 1990. PMID: 2243668

5

Effect of the tiapamil analog RO11-2933 on cellular sensitivity to antitumor drugs in sensitive and multidrug resistant human ovarian cancer cells.

Mazzoni A, Trave F, Canti G, Franco P. Mazzoni A, et al. Anticancer Res. 1989 Mar-Apr;9(2):367-71. Anticancer Res. 1989. PMID: 2751261

6

Cytoplasmic membrane cholesterol and doxorubicin cytotoxicity in drug-sensitive and multidrug-resistant human ovarian cancer cells.

Mazzoni A, Trave F. Mazzoni A, et al. Oncol Res. 1993;5(2):75-82. Oncol Res. 1993. PMID: 8364256

7

Membrane gangliosides and immuno-mediated cytolysis in drug sensitive and treatment-induced multidrug resistant human ovarian cancer cells.

Mazzoni A, Trave F, Fabbri M, Leto G, Ghidoni R. Mazzoni A, et al. Anticancer Res. 1991 Nov-Dec;11(6):2181-5. Anticancer Res. 1991. PMID: 1776860

8

In vitro reversal of doxorubicin resistance by the tiapamil analog RO 11-2933 in human ovarian cancer cells.

Mazzoni A. Mazzoni A. Tumori. 1990 Feb 28;76(1):69-72. doi: 10.1177/030089169007600119. Tumori. 1990. PMID: 2321277

9

CD3-CD28 costimulation as a means to avoiding T cell preactivation in bispecific monoclonal antibody-based treatment of ovarian carcinoma.

Mazzoni A, Mezzanzanica D, Jung G, Wolf H, Colnaghi MI, Canevari S. Mazzoni A, et al. Cancer Res. 1996 Dec 1;56(23):5443-9. Cancer Res. 1996. PMID: 8968099

10

Relationship between cytotoxicity, drug accumulation, DNA damage and repair of human ovarian cancer cells treated with doxorubicin: modulation by the tiapamil analog RO11-2933.

Alaoui Jamali MA, Yin MB, Mazzoni A, Bankusli I, Rustum YM. Alaoui Jamali MA, et al. Among authors: mazzoni a. Cancer Chemother Pharmacol. 1989;25(2):77-83. doi: 10.1007/BF00692343. Cancer Chemother Pharmacol. 1989. PMID: 2598402

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

716 results

Search Page

Filters